0001415889-24-001830.txt : 20240125 0001415889-24-001830.hdr.sgml : 20240125 20240125200032 ACCESSION NUMBER: 0001415889-24-001830 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240123 FILED AS OF DATE: 20240125 DATE AS OF CHANGE: 20240125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanderling Venture Partners VI Co Investment Fund LP CENTRAL INDEX KEY: 0001306695 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 24563794 BUSINESS ADDRESS: STREET 1: 1300 S EL CAMINO REAL SUITE 203 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: 650-401-2000 MAIL ADDRESS: STREET 1: 1300 S EL CAMINO REAL SUITE 203 CITY: SAN MATEO STATE: CA ZIP: 94402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanderling Venture Partners VI LP CENTRAL INDEX KEY: 0001306717 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 24563795 BUSINESS ADDRESS: STREET 1: 1300 S EL CAMINO REAL SUITE 203 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: 650-401-2000 MAIL ADDRESS: STREET 1: 1300 S EL CAMINO REAL SUITE 203 CITY: SAN MATEO STATE: CA ZIP: 94402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanderling Ventures Management VI CENTRAL INDEX KEY: 0001429588 ORGANIZATION NAME: FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 24563793 BUSINESS ADDRESS: STREET 1: 1300 S EL CAMINO REAL SUITE 203 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: (650) 401-2000 MAIL ADDRESS: STREET 1: 1300 S EL CAMINO REAL SUITE 203 CITY: SAN MATEO STATE: CA ZIP: 94402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanderling Ventures VII (Canada), L.P. CENTRAL INDEX KEY: 0001993660 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 24563790 BUSINESS ADDRESS: STREET 1: 1300 S. EL CAMINO REAL, SUITE 203 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: 650-401-2000 MAIL ADDRESS: STREET 1: 1300 S. EL CAMINO REAL, SUITE 203 CITY: SAN MATEO STATE: CA ZIP: 94402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanderling Ventures VII, L.P. CENTRAL INDEX KEY: 0001565862 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 24563792 BUSINESS ADDRESS: STREET 1: 400 SOUTH EL CAMINO REAL, SUITE 1200 CITY: SAN MATEO STATE: CA ZIP: 94402-1708 BUSINESS PHONE: 650-401-2011 MAIL ADDRESS: STREET 1: 400 SOUTH EL CAMINO REAL, SUITE 1200 CITY: SAN MATEO STATE: CA ZIP: 94402-1708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanderling Ventures VII Annex Fund, L.P. CENTRAL INDEX KEY: 0001678656 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 24563791 BUSINESS ADDRESS: STREET 1: 400 SOUTH EL CAMINO REAL, SUITE 1200 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: (650) 401-2011 MAIL ADDRESS: STREET 1: 400 SOUTH EL CAMINO REAL, SUITE 1200 CITY: SAN MATEO STATE: CA ZIP: 94402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanderling Ventures Management VII CENTRAL INDEX KEY: 0001993457 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 24563789 BUSINESS ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 203 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: 650-401-2000 MAIL ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 203 CITY: SAN MATEO STATE: CA ZIP: 94402 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CalciMedica, Inc. CENTRAL INDEX KEY: 0001534133 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 452120079 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 COAST BOULEVARD SOUTH STREET 2: SUITE 307 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-952-5500 MAIL ADDRESS: STREET 1: 505 COAST BOULEVARD SOUTH STREET 2: SUITE 307 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: CalciMedica, Inc. /DE/ DATE OF NAME CHANGE: 20230322 FORMER COMPANY: FORMER CONFORMED NAME: GRAYBUG VISION, INC. DATE OF NAME CHANGE: 20170717 FORMER COMPANY: FORMER CONFORMED NAME: GRAYBUG, Inc. DATE OF NAME CHANGE: 20150303 4 1 form4-01252024_080106.xml X0508 4 2024-01-23 0001534133 CalciMedica, Inc. CALC 0001306717 Sanderling Venture Partners VI LP 1300 S. EL CAMINO REAL SUITE 203 SAN MATEO CA 94402 false false true false 0001306695 Sanderling Venture Partners VI Co Investment Fund LP 1300 S EL CAMINO REAL SUITE 203 SAN MATEO CA 94402 0 0 1 0 0001429588 Sanderling Ventures Management VI 1300 S EL CAMINO REAL SUITE 203 SAN MATEO CA 94402 0 0 1 0 0001565862 Sanderling Ventures VII, L.P. 1300 S. EL CAMINO REAL SUITE 203 SAN MATEO CA 94402 0 0 1 0 0001678656 Sanderling Ventures VII Annex Fund, L.P. 1300 S EL CAMINO REAL SUITE 203 SAN MATEO CA 94402 0 0 1 0 0001993660 Sanderling Ventures VII (Canada), L.P. 1300 S. EL CAMINO REAL SUITE 203 SAN MATEO CA 94402 0 0 1 0 0001993457 Sanderling Ventures Management VII 1300 S. EL CAMINO REAL SUITE 203 SAN MATEO CA 94402 0 0 1 0 0 Common Stock 2024-01-23 4 P 0 243356 3.702 A 946744 D Common Stock 2024-01-23 4 P 0 144676 3.702 A 727433 I By Sanderling Venture Partners VI Co-Investment Fund, L.P. Common Stock 2024-01-23 4 P 0 194472 3.702 A 435148 I By Sanderling Ventures VII, L.P. Common Stock 2024-01-23 4 P 0 51032 3.702 A 114260 I By Sanderling Ventures VII (Canada), L.P. Common Stock 2024-01-23 4 P 0 13184 3.702 A 27609 I By Sanderling Ventures VII Annex Fund, L.P. Common Stock 2024-01-23 4 P 0 3920 3.702 A 21602 I By Sanderling Ventures Management VI Common Stock 2024-01-23 4 P 0 28744 3.702 A 30292 I By Sanderling Ventures Management VII Warrant 5.36 2024-01-23 4 P 0 121678 0.125 A 2024-01-23 2024-12-31 Common Stock 121678 121678 D Warrant 7.15 2024-01-23 4 P 0 121678 0.125 A 2024-01-23 2026-12-31 Common Stock 121678 121678 D Warrant 5.36 2024-01-23 4 P 0 72338 0.125 A 2024-01-23 2024-12-31 Common Stock 72338 72338 I By Sanderling Venture Partners VI Co-Investment Fund, L.P. Warrant 7.15 2024-01-23 4 P 0 72338 0.125 A 2024-01-23 2026-12-31 Common Stock 72338 72338 I By Sanderling Venture Partners VI Co-Investment Fund, L.P. Warrant 5.36 2024-01-23 4 P 0 97236 0.125 A 2024-01-23 2024-12-31 Common Stock 97236 97236 I By Sanderling Ventures VII, L.P. Warrant 7.15 2024-01-23 4 P 0 97236 0.125 A 2024-01-23 2026-12-31 Common Stock 97236 97236 I By Sanderling Ventures VII, L.P. Warrant 5.36 2024-01-23 4 P 0 25516 0.125 A 2024-01-23 2024-12-31 Common Stock 25516 25516 I By Sanderling Ventures VII (Canada), L.P. Warrant 7.15 2024-01-23 4 P 0 25516 0.125 A 2024-01-23 2026-12-31 Common Stock 25516 25516 I By Sanderling Ventures VII (Canada), L.P. Warrant 5.36 2024-01-23 4 P 0 6592 0.125 A 2024-01-23 2024-12-31 Common Stock 6592 6592 I By Sanderling Ventures VII Annex Fund, L.P. Warrant 7.15 2024-01-23 4 P 0 6592 0.125 A 2024-01-23 2026-12-31 Common Stock 6592 6592 I By Sanderling Ventures VII Annex Fund, L.P. Warrant 5.36 2024-01-23 4 P 0 1960 0.125 A 2024-01-23 2024-12-31 Common Stock 1960 1960 I By Sanderling Ventures Management VI Warrant 7.15 2024-01-23 4 P 0 1960 0.125 A 2024-01-23 2026-12-31 Common Stock 1960 1960 I By Sanderling Ventures Management VI Warrant 5.36 2024-01-23 4 P 0 14372 0.125 A 2024-01-23 2024-12-31 Common Stock 14372 14372 I By Sanderling Ventures Management VII Warrant 7.15 2024-01-23 4 P 0 14372 0.125 A 2024-01-23 2026-12-31 Common Stock 14372 14372 I By Sanderling Ventures Management VII The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors. The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter. The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter. /s/ Sanderling Venture Partners VI, L.P., By: /s/ Timothy C. Mills, Managing Director of Middleton, McNeil & Mills Associates VI, L.P., its General Partner 2024-01-25 /s/ Sanderling Venture Partners VI Co-Investment Fund, L.P., By: /s/ Timothy C. Mills, Managing Director of Middleton, McNeil & Mills Associates VI, LLC, its General Partner 2024-01-25 /s/ Sanderling Ventures VII (Canada), L.P., By: /s/ D. Michael Dixon, President of Sanderling Ventures VII (Canada) GP Inc., General Partner of Sanderling Ventures VII (Canada) G.P., L.P, its General Partner 2024-01-25 /s/ Sanderling Ventures VII, L.P. , By: /s/ Timothy C. Mills, Managing Director of M4 Partners VII, LLC, its General Partner 2024-01-25 /s/ Sanderling Ventures VII Annex Fund, L.P., By: /s/ Timothy C. Mills, Managing Director of M4 Partners VII Annex, LLC, its General Partner 2024-01-25 /s/ Sanderling Ventures Management VII, By: /s/ Timothy C. Mills, Owner 2024-01-25 /s/ Sanderling Ventures Management VI, By: /s/ Timothy C. Mills, Owner 2024-01-25